Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Anti-TNBC agent-3 (compound 3g) is a compound that induces apoptosis and possesses anti-cancer cell proliferation properties. It effectively inhibits tumor growth and metastasis in xenograft models of triple-negative breast cancer (TNBC) [1].
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | 6-8 weeks | $ 1,520.00 | |
50 mg | 6-8 weeks | $ 1,980.00 | |
100 mg | 6-8 weeks | $ 2,500.00 |
Description | Anti-TNBC agent-3 (compound 3g) is a compound that induces apoptosis and possesses anti-cancer cell proliferation properties. It effectively inhibits tumor growth and metastasis in xenograft models of triple-negative breast cancer (TNBC) [1]. |
In vitro | Anti-TNBC agent-3 (compound 3g) exhibits inhibitory activity against the proliferation of K562 and HepG2 cells, with IC50 values of 0.24 μM and 0.25 μM, respectively [1]. |
In vivo | Anti-TNBC Agent-3 (compound 3g) administered intraperitoneally (ip) at dosages of 10 mg/kg and 20 mg/kg inhibited tumor growth and metastasis in a mouse xenograft model of triple-negative breast cancer (TNBC) [1]. |
Molecular Weight | 539.66 |
Formula | C29H39F2N7O |
CAS No. | 2422001-25-8 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
anti-TNBC agent-3 2422001-25-8 inhibitor inhibit